CeADAR-Centre for Applied Data Analytics, University College Dublin, Dublin D04 V2N9, Ireland.
Kinesis Health Technologies Ltd., Belfield Office Park, Clonskeagh, Dublin D04 V2N9, Ireland.
Biosensors (Basel). 2020 Sep 20;10(9):128. doi: 10.3390/bios10090128.
Wearable devices equipped with inertial sensors enable objective gait assessment for persons with multiple sclerosis (MS), with potential use in ambulatory care or home and community-based assessments. However, gait data collected in non-controlled settings are often fragmented and may not provide enough information for reliable measures. This paper evaluates a novel approach to (1) determine the effects of the length of the walking task on the reliability of calculated measures and (2) identify digital biomarkers for gait assessments from fragmented data. Thirty-seven participants (37) diagnosed with relapsing-remitting MS (EDSS range 0 to 4.5) executed two trials, walking 20 m each, with inertial sensors attached to their right and left shanks. Gait events were identified from the medio-lateral angular velocity, and short bouts of gait data were extracted from each trial, with lengths varying from 3 to 9 gait cycles. Intraclass correlation coefficients (ICCs) evaluate the degree of agreement between the two trials of each participant, according to the number of gait cycles included in the analysis. Results show that short bouts of gait data, including at least six gait cycles of bilateral data, can provide reliable gait measurements for persons with MS, opening new perspectives for gait assessment using fragmented data (e.g., wearable devices, community assessments). Stride time variability and asymmetry, as well as stride velocity variability and asymmetry, should be further explored as digital biomarkers to support the monitoring of symptoms of persons with neurological diseases.
可穿戴设备配备惯性传感器,可对多发性硬化症 (MS) 患者进行客观的步态评估,具有在移动医疗、家庭和社区评估中应用的潜力。然而,在非受控环境中收集的步态数据通常是碎片化的,可能无法提供足够的信息来进行可靠的测量。本文评估了一种新方法,(1)确定行走任务的长度对计算得到的测量值的可靠性的影响,以及(2)从碎片化数据中识别用于步态评估的数字生物标志物。37 名诊断为复发缓解型多发性硬化症 (RRMS) 的参与者 (37 名) 用惯性传感器固定在他们的右小腿和左小腿上,完成了两个 20 米的行走任务。从横向角速度中识别出步态事件,并从每个试验中提取出短的步态数据片段,每个片段的长度从 3 到 9 个步态周期不等。根据分析中包含的步态周期数量,采用组内相关系数 (ICC) 评估每个参与者的两个试验之间的一致性程度。结果表明,包括至少 6 个双侧数据的步态数据短片段可以为 MS 患者提供可靠的步态测量,为使用碎片化数据(例如可穿戴设备、社区评估)进行步态评估开辟了新的视角。步长时间变异性和不对称性,以及步速变异性和不对称性,应该进一步作为数字生物标志物进行探索,以支持对神经系统疾病患者症状的监测。